Xingwei D. Sui, MD, PhD Providence Medical Group

Languages: English, Japanese, Chinese - Mandarin
Professional Statement
Dr. Sui earned a medical degree from Qingdao University, China, and a Ph.D. from the University of Tokyo, Japan. He conducted psotdoctoral research in hematology at Vanderbilt University, an internal medicine residency at the University of Tennessee, and a medical oncology fellowship at the Fred Hutchinson Cancer Research Center and the University of Washington. He is board certified in internal medicine and medical oncology. He as an associate pforessor at Shangdong. Dr. Sui believes in treating his patients as if they were his own family members.
MD, Qingdao (Tsingtao) Medical School, Qingdao, China PhD in Hematology and Stem Cell Biology, University of Tokyo, Japan
Medical School
Internal Medicine Residency, Baptist Hospital, University of Tennessee, Nashville, TN
Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN Department of Clinical Oncology and Pediatrics, University of Tokyo, Japan
Board Certifications
  • American Board of Internal Medicine, Medical Oncology
  • American Board of Internal Medicine, Internal Medicine
Clinical Interests
  • adverse effects to anticoagulants
  • amyloidosis
  • anemia
  • antithrombin deficiency
  • b12 deficiency anemia
  • bladder cancer genomics
  • blood cancer
  • blood disorders
  • bone marrow disorders
  • brain cancer genomics
  • breast cancer genomics
  • cancer
  • cancer chemotherapy
  • cancer during pregnancy
  • cancer genomics
  • cancer pain
  • cancer risk assessment
  • cancer survivorship
  • cancer-related fatigue
  • cervical cancer genomics
  • chemoradiation
  • colon cancer genomics
  • cowden syndrome
  • crizotinib
  • egfr mutation
  • egfr translocation
  • endocrine complications of cancer therapy
  • endometrial cancer genomics
  • erlotinib
  • factor v leiden
  • gallbladder cancer genomics
  • gastrointestinal cancer genomics
  • genitourinary cancer genomics
  • gynecologic cancer genomics
  • head and neck cancer care
  • head and neck cancer genomics
  • hellp syndrome
  • hemochromatosis
  • hemolytic uremic syndrome
  • heparin induced thrombocytopenia
  • hereditary spherocytosis
  • histiocytosis
  • hypogammaglobulinemia
  • idiopathic thrombocytopenic purpura
  • iron deficiency anemia
  • langerhans cell histiocytosis
  • leukemia genomics
  • leukocytosis
  • leukopenia
  • liver cancer genomics
  • lung cancer genomics
  • lymphoma genomics
  • lymphopenia
  • maternal hematologic disorders
  • melanoma genomics
  • monoclonal gammopathy of undetermined significance
  • musculoskeletal tumor
  • myelodysplasia
  • myelodysplastic syndrome
  • myeloproliferative diseases
  • neutropenia
  • non-hodgkin lymphoma
  • oral complications of cancer
  • pancreatic cancer genomics
  • pancytopenia
  • paroxysmal nocturnal hemoglobinuria
  • petechiae
  • peutz-jeghers syndrome
  • plasma cell dyscrasia
  • polycythemia
  • prostate cancer genomics
  • pulmonary metastases
  • purpura
  • radionuclide therapy
  • rectal cancer genomics
  • renal cancer genomics
  • retroperitoneal mass
  • rh incompatibility
  • sarcoma genomics
  • secondary polycythemia
  • side effects of cancer treatment
  • skin cancer genomics
  • splenomegaly
  • stomach cancer genomics
  • submucosal tumors
  • sweat gland carcinoma
  • thalassemia
  • thrombocytopenia
  • thrombophilia
  • thrombotic thrombocytopenic purpura
  • thyroid cancer genomics
  • tracheal cancer
  • unknown primary cancer
Dr. Sui has authored a book entitled Human Umbilical Cord Blood: Basic and Clinical Studies. He has also published over 25 original articles in peer-reviewed journals on many topics within the fields of oncology and hematology.

The Patient Rating score is based on responses given during the CAHPS Patient Experience Survey.Responses are measured on a 10 - point scale, with 10 being the best score. These scores are then translated to a 5 - point scale in order to display results in a 5 - star rating.Comments are also gathered from the same survey and displayed in their entirety with the exception of any language that may be considered slander, libel or contain private health information, which will be removed prior to publishing the comments.

4.8 out of 5 (163 Ratings, 0 Comments)

Providence Regional Cancer System - Lacey
4525 3rd Avenue Southeast Suite 200
Lacey, WA 98503
Providence Regional Cancer System - Aberdeen
954 Anderson Drive Suite 102
Aberdeen, WA 98520
Affiliated Facilities
Providence St. Peter Hospital
Providence Centralia Hospital